Exane Derivatives’s Wright Medical Group Inc WMGI Stock Holding History

Exane Derivatives’s Portfolio WMGI Stock Details WMGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-126	Closed	-$3.85K	–	883
2020 Q3	$3.85K	Hold	126	–	–	﹤0.01%	523
2020 Q2	$3.74K	Hold	126	–	–	﹤0.01%	467
2020 Q1	$3.61K	Hold	126	–	–	﹤0.01%	471
2019 Q4	$3.8K	Sell	126 -2,651	-95%	-$69.4K	﹤0.01%	455
2019 Q3	$57.3K	Hold	2,777	–	–	0.01%	363
2019 Q2	$82.8K	Hold	2,777	–	–	0.01%	348
2019 Q1	$87.3K	Buy	2,777 +1,222	+79%	+$37.1K	0.02%	311
2018 Q4	$42.3K	Buy	+1,555	New	+$43K	0.01%	371

Other funds holding WMGI

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Exane Derivatives's WMGI Position: Q4 2020 in Review

Exane Derivatives sold out of Wright Medical Group Inc (WMGI) in Q4 2020, closing a stake of 126 shares — an estimated $3.85K sold.

Exane Derivatives first reported a position in WMGI in Q4 2018 and held it in 8 quarters. The position peaked at $87.3K in Q1 2019. 1 fund tracked by Wall St. Rank holds WMGI as of Q4 2020.

Exane Derivatives reported no remaining Wright Medical Group Inc position as of Q4 2020 after selling out during the quarter.
Exane Derivatives sold 126 Wright Medical Group Inc shares in Q4 2020, an estimated $3.85K.
Exane Derivatives first reported a position in Wright Medical Group Inc in Q4 2018 and held it in 8 quarters.
Exane Derivatives's Wright Medical Group Inc position peaked at $87.3K in Q1 2019.
1 fund tracked by Wall St. Rank held Wright Medical Group Inc as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.